Atrioventricular septal defect cardiac catheterization: Difference between revisions

	Atrioventricular septal defect Microchapters
Home
Patient Information
Overview
Classification
Pathophysiology
Causes
Differentiating Atrioventricular septal defect from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
MRI
CT
Echocardiography
Cardiac Catheterization
Treatment
Medical Therapy
Surgery
Prevention
Pregnancy
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Atrioventricular septal defect cardiac catheterization On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Atrioventricular septal defect cardiac catheterization All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Atrioventricular septal defect cardiac catheterization
CDC on Atrioventricular septal defect cardiac catheterization
Atrioventricular septal defect cardiac catheterization in the news
Blogs on Atrioventricular septal defect cardiac catheterization
Directions to Hospitals Treating Type page name here
Risk calculators and risk factors for Atrioventricular septal defect cardiac catheterization

Revision as of 13:51, 3 October 2012

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Class IIa
"1.Cardiac catheterization is reasonable to assess PAH and test vasoreactivity in patients with repaired or unrepaired AVSD.(Level of Evidence: B) "

@@ Line 6: / Line 6: @@
 ==Cardiac Catheterization==
 ==ACC / AHA Guidelines- Recommendation for Heart Catheterization (DO NOT EDIT)==
-{{cquote|
+{| class="wikitable"
+|-
-===[[ACC AHA guidelines classification scheme#Classification of Recommendations|Class II a]]===
+| colspan="1" style="text-align:center; background:LemonChiffon"| [[ACC AHA guidelines classification scheme#Classification of Recommendations|Class IIa]]
+|-
-. Cardiac catheterization is reasonable to assess PAH and test vasoreactivity in patients with repaired or unrepaired AVSD. (Level of Evidence: B)}}
+| bgcolor="LemonChiffon"|<nowiki>"</nowiki>'''1.'''Cardiac catheterization is reasonable to assess PAH and test vasoreactivity in patients with repaired or unrepaired AVSD.([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: B]]) '' <nowiki>"</nowiki>
+|}
 ==References==